UK Piriformis Syndrome Market Research Report By Cause (Trauma, Spasms, Others)- Forecast to 2035
ID: MRFR/HC/55049-HCR | 200 Pages | Author: Rahul Gotadki| August 2025
As per MRFR analysis, the UK Piriformis Syndrome Market Size was estimated at 6.89 (USD Million) in 2023. The UK Piriformis Syndrome Market Industry is expected to grow from 7.8(USD Million) in 2024 to 12.1 (USD Million) by 2035. The UK Piriformis Syndrome Market CAGR (growth rate) is expected to be around 4.072% during the forecast period (2025 - 2035).
Key UK Piriformis Syndrome Market Trends Highlighted
One of the key market drivers in the UK Piriformis Syndrome Market is the rising awareness of musculoskeletal disorders and their impact on the population's quality of life. The UK's National Health Service (NHS) has been focusing on improving treatment options for various conditions, leading to increased attention towards the effective management of piriformis syndrome. Moreover, the growing prevalence of sedentary lifestyles among the UK's population has contributed to an uptick in cases related to this condition, as prolonged sitting can exacerbate symptoms.Â
This trend highlights the need for more targeted rehabilitation services and treatment modalities catering specifically to those suffering from piriformis syndrome.The UK market can be taken advantage of by creating new physiotherapeutic methods and specific movement regimes for the concerned individuals. The movement toward more personalized healthcare approaches is being adapted due to the UK’s healthcare system policies focusing on the comprehensive wellness of the individual.Â
This allows room for practitioners to develop new therapies that assist in the alleviation of pain and improvement of mobility for the patients. Moreover, the recent shift to the use of technology in treatment procedures is a remarkable trend in the UK. Patients, in particular, have greatly increased the use of telehealth services, which allows them to consult healthcare specialists without attending in person.
This evolution not only makes access to care easier for those with piriformis syndrome but also encourages more individuals to seek help, thereby driving market growth. Overall, as the UK continues to align with modern healthcare innovations, the piriformis syndrome market stands poised for significant development and enhancement in the years ahead.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
UK Piriformis Syndrome Market Drivers
Rising Awareness and Diagnosis of Piriformis Syndrome
The increasing awareness and understanding of Piriformis Syndrome in the UK is a significant driver for growth in the UK Piriformis Syndrome Market Industry. As healthcare professionals receive better training and resources from established organizations such as the National Health Service (NHS), there has been a noted increase in diagnosis rates.Â
Recent data indicates that neuromuscular disorders, including Piriformis Syndrome, have gained attention, with healthcare authorities reporting a 20% increase in diagnosed cases over the past five years.This heightened awareness has resulted in better patient outcomes and a growing demand for targeted treatments. The NHS has emphasized the importance of recognizing these conditions to facilitate early intervention, which further drives market growth as more patients seek appropriate care.
Advancements in Non-Surgical Treatment Options
Recent advancements in non-surgical treatment options for Piriformis Syndrome significantly contribute to the UK Piriformis Syndrome Market Industry's expansion. With the emergence of physiotherapy techniques and holistic treatment approaches, the reliance on surgical interventions is decreasing.Â
The Chartered Society of Physiotherapy reports an increase in the utilization of physical therapy interventions for neuromuscular disorders, promoting recovery without surgery.Studies indicate that approximately 60% of patients experience significant relief through these non-invasive approaches, leading to higher patient satisfaction rates. The availability of these innovative treatment modalities encourages more patients to seek treatment, thereby enhancing market growth.
Growing Elderly Population and Lifestyle Changes
The demographic shift towards an aging population in the UK is a crucial driver for the UK Piriformis Syndrome Market Industry. According to the Office for National Statistics, the proportion of elderly individuals aged 65 and over is projected to reach 23% by 2035. With age, individuals are more susceptible to ailments like Piriformis Syndrome due to factors such as degraded musculoskeletal health and reduced physical activity.Â
Furthermore, lifestyle changes that involve prolonged sedentary behavior are becoming common in the UK, thereby increasing the incidence of related muscular issues.This demographic trend signals a growing patient base for treatment solutions, contributing to market growth as healthcare providers increasingly cater to these needs.
Piriformis Syndrome Market Cause Insights
The UK Piriformis Syndrome Market, particularly the Cause segment, exhibits a diverse range of underlying reasons that contribute to this condition, impacting individuals across various demographics. One predominant factor is Trauma, which often arises from accidents or injuries that lead to inflammation or irritation of the piriformis muscle. The significance of trauma cannot be understated as it represents a primary trigger for many patients afflicted with Piriformis Syndrome.Â
Additionally, muscle Spasms are a critical contributor to this market segment, as they can develop due to overuse, prolonged sitting, or strenuous physical activity, leading to discomfort and pain in the gluteal region.This often results in reduced mobility and affects the overall quality of life, making it crucial to understand the prevalence of muscle spasms in managing Piriformis Syndrome. Moreover, the classification of other factors encompasses a diverse array of causes, which may include anatomical variations, postural issues, or nerve compression.Â
These other influences play a significant role in the broader scope of the UK Piriformis Syndrome Market, highlighting the multifactorial nature of this ailment. The vast array of causes not only complicates diagnosis and treatment but also indicates a substantial opportunity within the UK healthcare industry for innovative therapeutic solutions.Overall, acknowledging these causes is essential for reducing the burden of Piriformis Syndrome, improving the UK Piriformis Syndrome Market statistics, and ultimately leading to better patient outcomes.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
UK Piriformis Syndrome Market Key Players and Competitive Insights
The competitive landscape of the UK Piriformis Syndrome Market is characterized by a combination of specialized healthcare providers, rehabilitation centers, and integrated healthcare systems capable of addressing the complexities associated with this condition. Piriformis syndrome, which often results in pain radiating from the lower back to the legs, necessitates a multifaceted treatment approach that may involve physiotherapy, pain management strategies, and sometimes surgical intervention. Various players in the market compete primarily on the basis of expertise in musculoskeletal disorders, innovative treatment approaches, patient care quality, and overall reputation. The increasing awareness surrounding piriformis syndrome and advancements in treatment methodologies are driving the market dynamics, with healthcare providers continuously seeking to enhance their service offerings to attract a larger patient base.
The London Clinic stands out in the UK Piriformis Syndrome Market due to its distinguished reputation for advanced medical care and a focus on personalized patient treatment plans. Known for its multidisciplinary approach, The London Clinic offers a range of services that cater specifically to those suffering from conditions like piriformis syndrome. The strength of The London Clinic lies in its experienced team of specialists, which includes physiotherapists, orthopedic surgeons, and pain management experts, who work collaboratively to provide comprehensive care. This facility not only emphasizes quality clinical outcomes but also places a priority on patient comfort and satisfaction, enhancing its competitive edge within the piriformis syndrome landscape in the UK.
Nuffield Health is another influential player in the UK Piriformis Syndrome Market, known for its commitment to promoting holistic health and well-being. The organization provides a spectrum of treatments and services targeting musculoskeletal issues, including piriformis syndrome, through its extensive network of fitness centers and hospitals. Nuffield Health's strength lies in its integration of physical health services, such as physiotherapy and rehabilitation programs, coupled with lifestyle and fitness solutions tailored to individual patient needs. The company consistently strives to maintain a robust market presence by investing in advancements in treatment technologies and expanding its service lines, positioning itself as a key provider in the sector.Â
Furthermore, Nuffield Health's strategic focus on nurturing partnerships and exploring merger opportunities with other health organizations enhances its ability to deliver comprehensive care, thereby solidifying its strong position in the UK market for piriformis syndrome treatment.
Key Companies in the UK Piriformis Syndrome Market Include:
UK Piriformis Syndrome Market Industry Developments
The UK Piriformis Syndrome Market has experienced notable developments in recent months, with a growing emphasis on physiotherapy and advanced treatment options. The rise in awareness regarding the condition has led to an increase in services offered by organizations like The London Clinic, Nuffield Health, and HCA Healthcare, focusing on tailored physiotherapy treatments. In October 2023, Bupa announced an expanded collaboration with Bristol Physiotherapy aimed at enhancing patient access to specialized care for musculoskeletal disorders, including piriformis syndrome.Â
Additionally, a merger occurred in September 2023 between MediKidz and Aspire Physiotherapy, strengthening their combined outreach and expertise in pain management. The advancement in technology and treatment protocols has resulted in substantial growth in market valuation, positioning firms like Pure Sports Medicine and Ramsay Santé favorably within the industry.Â
Over the past two years, the UK market has seen a significant investment in Research and Development, leading to innovative therapies and improved patient outcomes. Collaboration among physiotherapy clinics, especially in major cities, has enhanced service delivery, benefiting patients with piriformis syndrome. Overall, the market trend is leaning towards integrated healthcare solutions focusing on individualized care.
UK Piriformis Syndrome Market Segmentation Insights
Piriformis Syndrome Market Cause Outlook
Report Attribute/Metric Source: | Details |
MARKET SIZE 2023 | 6.89(USD Million) |
MARKET SIZE 2024 | 7.8(USD Million) |
MARKET SIZE 2035 | 12.1(USD Million) |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.072% (2025 - 2035) |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR | 2024 |
MARKET FORECAST PERIOD | 2025 - 2035 |
HISTORICAL DATA | 2019 - 2024 |
MARKET FORECAST UNITS | USD Million |
KEY COMPANIES PROFILED | The London Clinic, Nuffield Health, CryoHealth, Pure Sports Medicine, Sports Medicine Centre, Physio Matters, PhysioSphere, Physiotherapy Clinics, Ramsay Santé, HCA Healthcare, Aspire Physiotherapy, MediKidz, Bristol Physiotherapy, The Physiotherapy Clinic, Bupa |
SEGMENTS COVERED | Cause |
KEY MARKET OPPORTUNITIES | Telehealth physical therapy solutions, Targeted pain relief medications, Innovative treatment modalities, Awareness and education programs, Personalized rehabilitation plans |
KEY MARKET DYNAMICS | increased awareness and diagnosis, growing prevalence of hip pain, rise in physiotherapy services, advancements in treatment options, expanding telehealth consultations |
COUNTRIES COVERED | UK |
Frequently Asked Questions (FAQ) :
The UK Piriformis Syndrome Market is expected to be valued at 7.8 million USD in 2024.
By 2035, the UK Piriformis Syndrome Market is projected to reach 12.1 million USD.
The expected CAGR for the UK Piriformis Syndrome Market from 2025 to 2035 is 4.072%.
The Trauma segment is expected to hold a significant market share, valued at 4.9 million USD by 2035.
Key players in the market include The London Clinic, Nuffield Health, and CryoHealth among others.
The Spasms segment is expected to be valued at 4.0 million USD in 2035.
The Others segment is anticipated to grow to 3.2 million USD by 2035.
Key growth drivers include an increasing awareness of Piriformis Syndrome and advancements in treatment options.
Challenges include fluctuating healthcare regulations and varying access to treatment across regions.
The competitive landscape is robust with numerous players offering specialized treatments for Piriformis Syndrome.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)